Let's review the charts and indicators.
Trading action has been jumpy, so where's the trend?
You can't rush drugs to market and you can't rush a market bottom.
With a $1 trillion bond, we could be sure that we have national testing and everyone has to be tested, we could actually build the PPE factories and put people to work.
Most of the media continues to focus on the national response to the coronavirus.
I don't think it would be too much of a stretch to imagine that too many investors, or citizens for that matter, will mind seeing March 2020 head on out of here.
St. Louis Fed Pres. James Bullard sees unemployment possibly hitting 30%, while GDP could ultimately contract 50%.
Fujifilm Holdings has a promising drug that seems to work in improving the outcome for coronavirus patients in China and Japan, though Avigan is a treatment not a cure.
I am pretty well covered in my 'virus group'. I could definitely see bringing a few shares of REGN on board the next time the algorithms include that name in a broad selloff. Not before.
LLY is entering into a new partnership with AbCellera Biologics in an attempt to develop an antibody for Covid-19.